Use of compatible solutes as adjuvants for vaccines
AU9546901A
Cosmetic formulations
WO0176572A2
Use of compatible solutes as substances having free radical scavenging properties
DE10064401A1
Pharmaceutical formulation, especially a vaccine, e.g. against polio or parvovirus, contains proteins, peptides and/or nucleic acids as well as compatible solutes
DE10065986A1
Pharmaceutical formulation, especially a vaccine, e.g. against polio or parvovirus, contains proteins, peptides and/or nucleic acids as well as compatible solutes
DE10047444A1
Process for the separation and high-purity isolation of low-molecular, structurally similar compounds, in particular of tetrahydropyrimidine derivatives such as e.g. 1,4,5,6-tetrahydro-2-methyl-4-pyrimidinecarboxylic acids (ectoins) and their cleavage products
DE10055706A1
Cosmetic or dermatological topical formulation, useful for the protection of skin cells from physical, chemical or biological effects, contains a di-sugar alcohol phosphate of 3-6C sugar alcohols
DE10040932A1
Cosmetic or dermatological topical formulation, useful for the protection of skin cells from physical, chemical or biological effects, contains a di-sugar alcohol phosphate of 3-6C sugar alcohols
DE10040933A1
Use of beta-mannosylglycerate (Firoin) and / or derivatives, in particular beta-mannosylglyceramide (Firoin-A), in cosmetic and dermatological formulations
DE10040931A1
Use of cyclic 2,4-diphosphoglycerate (cDGP) and / or derivatives in cosmetic and dermatological formulations
EP1125583A1
Use of compatible solutes as inhibitors of the enzymatic degradation of macromolecular biopolymers
WO9731682A1
Process for microbial decomposition of harmful substances in media charged with harmful substances, and micro-organisms suitable for this purpose
DE19507103C1
Processes for the cultivation of microorganisms
EP0748373A1
Micro-organism culture method
DE4335332A1
Method and device for in particular non-invasively determining at least one parameter of interest in a fluid pipe system
